Lantheus agreed to be acquired by Curium for $102.50 per share in cash plus up to $12.00 per share in contingent value rights.

Key Highlights:

  • Definitive merger agreement: Curium US to acquire Lantheus for $102.50/share cash at closing.
  • Additional upside: non-transferable CVRs could add up to $12.00/share based on specified sales milestones.
  • Transaction value: up to $114.50/share and up to approximately $8.0 billion total; Board unanimously approved.
  • Timing & conditions: expected close in 1H 2027, subject to shareholder and regulatory approvals and customary conditions.
  • Operational impact: Lantheus pauses CEO search, will suspend FY2026 guidance and remain public until closing.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.